1. Introduction {#sec1-nutrients-12-01013}
===============

Metabolic syndrome (MetS) is responsible for a 2.5-fold increased cardiovascular mortality, 5-fold increased risk of diabetes, 2-fold higher risk of coronary heart disease and cerebrovascular disease and 1.5-fold increase in the risk of all-cause mortality \[[@B1-nutrients-12-01013]\].

The prevalence of MetS is a major public health concern. Nearly 35% of all adults and 50% of those aged 60 years or older are estimated to have MetS in the US population \[[@B2-nutrients-12-01013]\] and nearly 31% in Spain \[[@B3-nutrients-12-01013]\]. This data is alarming, given the aging world population being a major contributor to the growing prevalence of MetS. Otherwise, the total cost of the MetS, including the cost of health care and loss of potential economic activity, is in trillions, and costs are likely to increase in the future.

The risk of developing MetS increases with the lack of physical activity (PA), which is also an important component of cardiovascular diseases (CVD) development \[[@B4-nutrients-12-01013],[@B5-nutrients-12-01013]\]. Strong evidence shows that high amounts of sedentary behaviour have been associated with increased risk of several chronic conditions, mortality \[[@B6-nutrients-12-01013]\], and higher likelihood of MetS \[[@B7-nutrients-12-01013]\]. MetS has been bidirectionally associated with depression \[[@B8-nutrients-12-01013]\]. Diet has a potential role in the prevention and treatment of MetS; higher adherence to the Mediterranean diet (MD) can reduce cardiometabolic risk factors \[[@B9-nutrients-12-01013]\] and the prevalence of MetS, and cause reversion of this condition \[[@B10-nutrients-12-01013]\].

The binary nature of the MetS (presence/absence) does not allow for an exact estimation of the risk of MetS. In addition, certain components may be more strongly linked to MetS \[[@B11-nutrients-12-01013]\]. In this way, the MetS Severity Score (MetSSS) quantifies the cumulative amount of risk derived from the presence of MetS risk factors \[[@B12-nutrients-12-01013]\]. Given the lack of studies focused on the severity of the MetS in older populations, this study aimed to report leisure-time physical activity, sedentary behaviour, and diet quality according to the MetS severity.

2. Methods {#sec2-nutrients-12-01013}
==========

2.1. Study Design {#sec2dot1-nutrients-12-01013}
-----------------

This research was a cross-sectional analysis of baseline data within the frame of the Prevención con Dieta Mediterránea (PREDIMED-Plus) trial, an ongoing six-year multicentre, parallel-group, randomised trial conducted in Spain, in order to evaluate the effect of a weight loss intervention programme based on an energy-restricted traditional MD, with physical activity promotion and behavioural support on cardiovascular disease morbimortality, compared with the usual care advice, consisting exclusively of an energy unrestricted traditional MD (control group). Details of the PREDIMED-Plus study protocol are fully described \[[@B13-nutrients-12-01013]\] and available at <http://predimedplus.com/>. The trial was registered in 2014 at the International Standard Randomized Controlled Trial (ISRCT; <http://www.isrctn.com/ISRCTN89898870>) with number 89898870.

2.2. Participants, Recruitment, Randomization, and Ethics {#sec2dot2-nutrients-12-01013}
---------------------------------------------------------

Eligible participants were community-dwelling adults (aged 55--75 in men; 60--75 in women; this sex--age range was chosen depending on the age that each gender is at high risk of suffering non-communicable diseases, the association of MetS with CVD, and the increasing prevalence of MetS with age), without documented history of CVD at enrolment, who were overweight or obese (body mass index (BMI) ≥ 27 and \<40 kg/m^2^) and who met at least three criteria for MetS according to the updated harmonized definition of the International Diabetes Federation and the American Heart Association, and National Heart, Lung, and Blood Institute \[[@B14-nutrients-12-01013]\].

From 5 September 2013 to 31 December 2016, a total of 9677 people was contacted, of which 6874 participants were recruited in 23 Spanish centres (universities, hospitals, and research institutes). However, the present analysis included 5739 subjects (2739 women) ([Figure 1](#nutrients-12-01013-f001){ref-type="fig"}). Participants who did not respond to all physical activity (PA) questionnaires (*n* = 234) and participants reporting outliers for total PA (*n* = 117) expressed as metabolic equivalents of task (METs·min/week (at 3 or more standard deviations (SD) from the mean for each sex and age)) were excluded. Participants (*n* = 181) recording extreme total energy intakes (\<500 or \>3500 kcal/day in women or \<800 or \>4000 kcal/day in men), participants without information from food frequency questionnaires (FFQ) (*n* = 43), and those without total information on cardiovascular risk factors (*n* = 560) were also excluded.

All participants provided written informed consent. The study protocol and procedures were approved according to the ethical standards of the Declaration of Helsinki by all the participating institutions. The trial was registered at the International Standard Randomized Controlled Trial (ISRCTN: <http://www.isrctn.com/ISRCTN89898870>) with number 89898870 and registration date of 24 July 2014, retrospectively registered.

2.3. Anthropometric and Blood Pressure Measurements {#sec2dot3-nutrients-12-01013}
---------------------------------------------------

Weight and height were measured by registered dietitians with calibrated scales and a wall-mounted stadiometer, respectively. BMI was calculated as weight in kilograms divided by the square of height in meters. Waist circumference (WC) was measured halfway between the last rib and the iliac crest by using an anthropometric tape. Systolic (SBP) and diastolic blood pressure (DBP) and heart rate (HR) were measured in triplicate with a validated semi-automatic oscillometer (Omron HEM-705CP, Lake Forest, IL, USA) after 5 min of rest in-between measurements while the participant was in a seated position. All anthropometric variables were determined in duplicate.

2.4. Blood Collection Analysis {#sec2dot4-nutrients-12-01013}
------------------------------

Samples of fasting blood were collected after an overnight fast and biochemical analyses were performed on fasting plasma glucose, glycosylated haemoglobin (HbA1c), total cholesterol, high-density lipoprotein cholesterol (HDL-c), and triglycerides (TAG) concentrations in local laboratories using standard enzymatic methods, whereas low-density lipoprotein cholesterol (LDL-c) was calculated by the Friedewald formula.

2.5. Other Health Outcomes {#sec2dot5-nutrients-12-01013}
--------------------------

Additional information related to sociodemographic and lifestyle aspects (education level, civil status, smoking habits, individual and family medical history, and current medication use) was collected. Furthermore, depressive symptoms were measured through the Beck Depression Inventory-II (BDI) validated in Spain. The Beck Depression Inventory-II includes 21 questions with four possible answers sorted according to depressive symptom severity, and scores range from 0 to 63 points \[[@B15-nutrients-12-01013]\].

2.6. Visceral Adiposity Index {#sec2dot6-nutrients-12-01013}
-----------------------------

Visceral adiposity was assessed by calculating the visceral adiposity index (VAI) according to previously validated equations \[[@B16-nutrients-12-01013]\]. VAI was defined as the following equations:$$Men:~~VAI = \left( \frac{WC}{39.68 + \left( {1.88 \times BMI} \right)} \right) \times \left( \frac{TAG}{1.03} \right) \times \left( \frac{1.31}{HDL - c} \right)$$ $$Women:~~~VAI = \left( \frac{WC}{36.58 + \left( {1.89 \times BMI} \right)} \right) \times \left( \frac{TAG}{0.81} \right) \times \left( \frac{1.52}{HDL - c} \right)$$

VAI was formulated assuming VAI = 1 for healthy non-obese subjects with normal adipose distribution and normal TAG and HDL-c levels.

2.7. Physical Activity and Sedentary Behaviour {#sec2dot7-nutrients-12-01013}
----------------------------------------------

Leisure time physical activity (LTPA) was measured using the Rapid Assessment of Physical Activity Questionnaires (RAPA-1 and RAPA-2) \[[@B17-nutrients-12-01013]\] and the validated Minnesota-REGICOR (Registre Gironí del Cor) Short Physical Activity questionnaire \[[@B18-nutrients-12-01013]\], including questions to collect information on the type of activity, frequency (number of days), and duration (min/day). METs were calculated by multiplying the intensity (showed by the MET score) and the duration spent on that activity (measured in minutes). The intensity was assigned based on the compendium of PA. According to PA intensity, activities were categorized into light PA (\<4.0 MET), moderate PA (4--5.5 MET), and vigorous PA (≥6.0 MET).

The 30 s chair stand test was used as an indicator of lower-limb muscle strength. This test was done at the same desk that dietary assessment and anthropometric measurements were done, and was provided by registered technicians in physical activity. As reported, performance was based on the number of times participants could stand and sit on a chair in 30 s \[[@B19-nutrients-12-01013]\].

Sedentary behaviours were measured using the validated Spanish version of the Nurses' Health Study questionnaire to assess sedentary behaviours \[[@B20-nutrients-12-01013]\], consisting of a set of open-ended questions assessing the average daily time spent over the last year in watching TV, sitting while using the computer, sitting on journeys (for work purposes or leisure time, as the driver or passenger in a car, subway, bus, employment status, retirement) and total sitting. Answers included 12 categories ranging from 0 to ≥9 h/day of sitting time for the corresponding activity. Furthermore, participants reported their average daily sleeping time for both weekdays and weekends, using the non-validated open question, "How many hours do you sleep on average per day on weekdays and weekends?"

2.8. Dietary Assessment {#sec2dot8-nutrients-12-01013}
-----------------------

Registered dietitians collected data on dietary intake with a semi-quantitative 143-item FFQ, assessing dietary habits over the previous 12 months, validated in Spain \[[@B21-nutrients-12-01013]\]. Detailed information about the development, reproducibility, and validity of FFQ in the PREDIMED cohort has been previously reported. For each item, a typical portion size was included, and consumption frequencies were registered in nine categories that ranged from "never or almost never" to "≥6 times/day". Energy and nutrient intakes were calculated as frequency multiplied by nutrient composition of the specified portion size for each food item, using a computer program based on available information in food composition tables \[[@B22-nutrients-12-01013]\]. The selected frequency item was converted to a daily intake. For example, if a response was 5--6 times a week, it was converted to 0.78 servings per day (5.5 times/week). For each FFQ food item, we estimated the average amount of food consumed (grams), the average total energy intake, and the average intake of a set of macro- and micro-nutrients by computing the mean of the values for the individual foods assigned to that item. We also considered the total nutrient intake, and the average intake of micronutrients from dietary supplements declared by participants in the FFQ.

2.9. Assessment of Mediterranean Diet Adherence {#sec2dot9-nutrients-12-01013}
-----------------------------------------------

Participants were also administered a 17-item Mediterranean dietary questionnaire, a modified version of the previously validated questionnaire used in the PREDIMED trial designed to assess adherence to MD. Compliance with each of the 17 items relating to characteristic food habits was scored with 1 and 0 points. Therefore, the total score range was 0--17, with 0 meaning no adherence and 17 meaning maximum adherence \[[@B23-nutrients-12-01013]\].

2.10. Dietary Inflammatory Index {#sec2dot10-nutrients-12-01013}
--------------------------------

The Dietary Inflammatory Index (DII) is a score used to assess the inflammatory potential of a diet, as previously described \[[@B24-nutrients-12-01013]\]. The score reports the effect of 45 food parameters on six inflammatory biomarkers (interleukins (IL-1B, IL-4, IL-6, IL-10), Tumour Necrosis Factor-alpha (TNF-α), and highly sensitive C-Reactive Protein \[CRP\]), consisting of whole foods, nutrients, and other bioactive compounds derived from a much larger literature review. The food parameters obtained a positive score according to whether its effect was pro-inflammatory (significantly increased IL-1β, IL-6, TNF-α, or CRP, or decreased IL-4 or IL-10), a negative score if its effect was anti-inflammatory, and 0 if no significant change in inflammatory biomarkers was found. The DII is based on dietary intake derived from the validated FFQ used in the PREDIMED-Plus trial. The individual intake of each food parameter was subtracted from a global standard database, and then divided by the world standard deviation for each food parameter. These values were converted to a percentile score, each percentile was doubled, and then 1 was subtracted to achieve a symmetrical distribution (from −1 to +1 and centred on 0). Afterwards, each one of these values was multiplied by the overall food parameter specific inflammatory score. Finally, the sum of all the food parameter specific DII scores provided the overall DII score for everyone. Thus, positive DII scores represent a pro-inflammatory diet and negative DII scores represent an anti-inflammatory diet. In this way, we considered the following food parameters to calculate the DII: alcohol, carbohydrate, cholesterol, energy, iron, fibre, folic acid, garlic, green/black tea, magnesium, monounsaturated fatty acids (MUFA), omega-3 fatty acids (w-3 FA), omega-6 fatty acids, niacin, onion, protein, polyunsaturated fatty acids (PUFA), riboflavin, saturated fatty acids (SFA), selenium, thiamine, total fat, trans fatty acids (TFA), vitamin A, vitamin B12, vitamin B6, vitamin C, vitamin D, vitamin E, and zinc.

2.11. Metabolic Syndrome Severity Score {#sec2dot11-nutrients-12-01013}
---------------------------------------

The Metabolic Syndrome Severity Score (MetSSS) was calculated as previously described \[[@B12-nutrients-12-01013]\]. A MetSSS value of zero indicates that subjects were at or below clinical thresholds for all MetS risk factors (WC, TAG, HDL, SBP, DBP, glucose). Similarity in scores across sex, age, and medication subgroups, confirms the validity of using this standard, robust, and generalizable formula \[[@B12-nutrients-12-01013]\]. MetSSS was categorized in tertiles, being the cut-off points 2.7 and 4.0. The first tertile (T1) represents the sample with the lowest severity of risk factors for cardio-metabolic disease and the third tertile (T3) represents the sample with the highest severity of risk factors for cardio-metabolic disease.

2.12. Statistics {#sec2dot12-nutrients-12-01013}
----------------

Analyses were performed with the SPSS statistical software package version 25.0 (SPSS Inc., Chicago, IL, USA). Qualitative data are shown as prevalence, and differences across tertiles of MetSSS were examined using the chi-square test. Quantitative data are shown as mean, standard deviation (SD), or median and interquartile range (IQR). In [Table 1](#nutrients-12-01013-t001){ref-type="table"}, normality of data was assessed using the Kolmogorov--Smirnov test and, as age was non-normally distributed, the Kruskal--Wallis test was used to compare differences in means among tertiles using Bonferroni post-hoc correction. In [Table 2](#nutrients-12-01013-t002){ref-type="table"}, [Table 3](#nutrients-12-01013-t003){ref-type="table"}, [Table 4](#nutrients-12-01013-t004){ref-type="table"} and [Table 5](#nutrients-12-01013-t005){ref-type="table"}, differences in means among tertiles of MetSSS were tested by one-factor analysis of variance (ANOVA). Equality of variances was assessed with Levene's test. In addition, analysis of covariance (ANCOVA) was used in order to assess the difference in means among tertiles of MetSSS, adjusted for potential confounding. Bonferroni post-hoc correction was used for multiple comparisons to control type I error. Results were considered statistically significant if the *p*-value (2 tailed) \<0.05.

3. Results {#sec3-nutrients-12-01013}
==========

[Table 1](#nutrients-12-01013-t001){ref-type="table"} shows general characteristics of participants according to tertiles of MetSSS. There were significant differences in all variables, except for hypertriglyceridemia. Specifically, the percentage of women and the prevalence of obesity, high blood pressure (BP), hyperglycaemia, low HDL cholesterol and abdominal obesity, and the prescription of antihypertensive agents, anti-cholesterol agents, insulin, oral hypoglycaemic agents, and aspirin or antiplatelet drugs increased with increasing MetS severity, whereas the education level decreased. Women showed significantly higher MetSSS compared to men (3.68 ± 1.37 vs. 3.25 ± 1.44, *p* \< 0.001). Participants with lowest MetS severity included a higher percentage of those who were married, workers, and former smokers, whereas participants with the highest MetSSS included a lower percentage of married and retired participants, current smokers, and a higher percentage of non-workers; 58.0% of non-smokers were women, representing 93.5% of women in T3, vs. 38.8% of non-smokers women in T1, representing 91.3% of total women in T1.

Cardiovascular risk factors and BDI according to tertiles of MetSSS are shown in [Table 2](#nutrients-12-01013-t002){ref-type="table"}. After full adjustment, there were significant differences in all variables among tertiles, except for total cholesterol and LDL-c. Weight, BMI, WC, glucose, HbA1C, TAG, SBP, DBP, HR, and VAI increased significantly with increasing MetS severity. BDI was higher in T3 (tertile with the highest MetSSS), and HDL-c was higher in T1.

PA parameters and sedentary behaviour are shown in [Table 3](#nutrients-12-01013-t003){ref-type="table"}. The 30 s chair stand test decreased with increasing MetS severity. Total sedentary and TV-viewing time were significantly lower in T1 (tertile with the lowest MetSSS) compared with T3, whereas total, moderate, and vigorous LTPA were significantly higher. No significant differences were found in light LTPA and sleeping time.

[Table 4](#nutrients-12-01013-t004){ref-type="table"} shows nutrient intake characteristics of the total sample according to tertiles of MetSSS. After full adjustment, SFAs were significantly lower in T1 participants, whereas carbohydrate intake was significantly higher. T3 participants showed higher intake of protein, total fat, SFA, TFA, cholesterol, iodine, and sodium compared with T1. After adjusting for sex and age, w-3 FA intake was significantly lower in T3 compared to T1, but this significance was lost when adjusting for all demographic variables. No significant differences were found in total energy, MUFA, PUFA, linoleic acid, glycaemic index, fibre, alcohol, vitamin and mineral intake, except for iodine and sodium.

[Table 5](#nutrients-12-01013-t005){ref-type="table"} shows food consumption, DII, and adherence to MD of participants according to tertiles of MetSSS. After full adjustment, total meat intake significantly decreased with decreasing MetS severity. In addition, red and processed meat intake was significantly lower in T1 compared to T3, whereas nut intake was significantly higher. T3 participants showed significantly lower intake of nuts and significantly higher intake of red and processed meat, and oils different from olive oil and spirit alcoholic drinks, compared with T1. After adjusting for sex and age, MD adherence was statistically significantly higher in T1 compared to T3 participants, whereas DII and white meat intake were significantly lower in T1, compared with the positive and significantly higher DII in T3 participants, but this significance was lost when adjusting for all demographic variables. No differences were found in fruits, vegetables, potatoes, legumes, cereals, fish and seafood, eggs, dairy products, olive oil, snacks, and wine and beer intake.

4. Discussion {#sec4-nutrients-12-01013}
=============

To the best of our knowledge, this is the first study that has examined LTPA, sedentary behaviour, and dietary characteristics in older adults with MetS according to the MetS severity score (MetSSS). The most relevant observation of this study was that participants with the highest MetSSS (T3) showed higher levels of sedentary time and depression risk and lower total LTPA, and they also tended to have a pro-inflammatory dietary pattern and tended to have lower MD adherence. Conversely, participants with the lowest MetSSS (T1) showed lower levels of sedentary time and depression risk and higher total LTPA, and they tended to have an anti-inflammatory dietary pattern and tended to have higher adherence to MD. Concretely, T3 participants showed lower carbohydrate and nut intake and moderate and vigorous LTPA, which is associated with higher risk of CVD \[[@B4-nutrients-12-01013],[@B5-nutrients-12-01013],[@B25-nutrients-12-01013]\]. Conversely, T3 showed higher intake of protein, SFA, TFA, cholesterol, as well as higher consumption of red and processed meat, and other oils different from olive oil and spirits compared with T1, resulting in an increased risk of several major chronic diseases \[[@B26-nutrients-12-01013],[@B27-nutrients-12-01013]\].

4.1. Sociodemographic Factors {#sec4dot1-nutrients-12-01013}
-----------------------------

Previous evidence has shown an association between married individuals and a lower incidence of CVD and coronary heart disease (CHD) and lower CHD and stroke mortality compared with unmarried individuals \[[@B28-nutrients-12-01013]\], which is in agreement with our results, where a majority of the participants with lower levels of MetSSS were married. Our results in which women showed higher levels of MetSSS is in agreement with previous observations in which women showed a higher risk of CV mortality attributed to the higher prevalence of MetS in elderly women \[[@B29-nutrients-12-01013]\] and the distribution of central adiposity, insulin resistance, and hormonal regulation \[[@B30-nutrients-12-01013]\]. In accordance with our results showing that retired participants were less frequent in the highest MetSSS tertiles, previous observations have associated retirement with increasing LTPA \[[@B31-nutrients-12-01013]\]. Smoking is associated with MetS and its individual components, and smoking cessation is beneficial to MetS \[[@B32-nutrients-12-01013]\]. This is contrary to our results in which those participants with the highest MetSSS were mainly non-smokers, perhaps due to a higher percentage of women in T3 participants. Previous evidence has shown that women smoke less than men \[[@B33-nutrients-12-01013]\], which is in accordance with our results. Educational level decreased with increasing MetSSS, which is in accordance with previous observations \[[@B34-nutrients-12-01013]\] in which an inverse association between educational level and MetS was found.

4.2. Cardiovascular Risk Factors {#sec4dot2-nutrients-12-01013}
--------------------------------

An increase in cardiovascular risk factors (weight, BMI, WC, glucose, HbA1c, TAG, SBP, and DBP) with increasing MetSSS and an increase in HDL-c in participants with lower MetSSS were similar to previous findings, in which the MetSSS improved prediction of diabetes and CHD \[[@B11-nutrients-12-01013]\]. Furthermore, resting HR is an indicator of the autonomic nervous system. High HR represents an imbalance in the central nervous system, which is closely associated with insulin resistance. Resting HR increased as MetSSS did, and this agrees with previous observations that have suggested an increased risk of MetS with increasing HR \[[@B35-nutrients-12-01013]\]. In addition, VAI is a novel mathematical model to estimate visceral adiposity and is a good indicator of adipose tissue dysfunction, being the optimal VAI cut-off value around 1.0. High VAI values are associated with poor future metabolic outcomes and is related with higher cardiometabolic risk \[[@B16-nutrients-12-01013]\]. This correlates with our results in which VAI increased with increasing MetSSS. Despite that, total cholesterol and LDL cholesterol tended to be lower in participants with higher MetSSS, though after adjusting for the medication used, this significance disappeared.

4.3. Depressive Symptoms {#sec4dot3-nutrients-12-01013}
------------------------

Depressive symptoms are associated with prevalent and incident frailty in the older population, which is associated with activities of daily living impairment, hospitalization, and death. Our analysis on depressive symptoms showed that risks of depression increased with increasing MetS severity, which is in accordance with previous results that show a bidirectional association between depression and MetS \[[@B8-nutrients-12-01013]\]. Other authors suggested that psychological characteristics, especially depression, may increase risks of MetS \[[@B36-nutrients-12-01013]\]. Comparing our results with previous findings \[[@B37-nutrients-12-01013]\], our participants showed a higher risk of depression, especially among MetSSS participants of highest severity.

4.4. Sedentary Behaviour and Physical Activity {#sec4dot4-nutrients-12-01013}
----------------------------------------------

Strong evidence has shown that high amounts of sedentary behaviour are associated with increased risks of several chronic conditions and mortality \[[@B5-nutrients-12-01013],[@B6-nutrients-12-01013],[@B38-nutrients-12-01013]\]. Prolonged TV viewing time is associated with an increased risk of type 2 diabetes mellitus (T2DM), CVD, and all-cause mortality \[[@B36-nutrients-12-01013]\]. Other authors showed that prolonged sedentary time is independently associated with deleterious health outcomes, regardless of PA \[[@B6-nutrients-12-01013]\]. Such results are strongly related to our findings, in which sedentary time and TV-viewing were higher in the highest MetSSS participants. In addition, our results are similar to previous observations in which total sedentary time increased as the number of MetS components did \[[@B39-nutrients-12-01013]\], and greater levels of sedentary time, independent of other levels of PA, was associated with being metabolically unhealthy and high levels of sedentary time were strongly related to a higher likelihood of MetS \[[@B7-nutrients-12-01013]\].

Previous evidence has shown that PA decreases the risk of developing MetS and is an important component of CVD prevention \[[@B40-nutrients-12-01013]\]. Conversely, the lack of PA is a major cause of chronic diseases and suggests an inverse relationship between PA level and MetS, obesity, non-alcoholic fatty liver disease, and T2DM. An excess of weight and lack of PA are two important determinants of MetS \[[@B4-nutrients-12-01013]\]. Lack of PA explains a greater amount of the variance of MetS than any other factors of lifestyle, education, sex, and family history, and substantially mitigates the strong association of age and BMI with MetS \[[@B12-nutrients-12-01013],[@B41-nutrients-12-01013]\]. Previous findings have also shown that high levels of moderate-intensity PA seem to decrease the increased risk of death associated with high sitting time, and to mitigate the increased risk associated with high levels of TV-viewing time \[[@B42-nutrients-12-01013]\]. Therefore, all these findings agree with our results (lack of PA among the highest MetSSS subjects).

Lower-body strength is important for the maintaining of functional mobility and preventing or delaying the onset of disability, and the chair stand test provides information on declines in mobility in older adults and is a measure used to identify frail individuals \[[@B19-nutrients-12-01013]\]. Compared to non-institutionalized Spanish older adults \[[@B43-nutrients-12-01013]\], our highest MetSSS participants showed less repetitions in the chair stand test, and thus, less low-body strength.

4.5. Dietary Characteristics {#sec4dot5-nutrients-12-01013}
----------------------------

MD is characterized by high consumption of fruits and vegetables, legumes, nuts and whole cereals, and a high intake of olive oil, but low-to-moderate consumption of dairy products, low intake of meat and poultry, and regular, but moderate intake of wine \[[@B44-nutrients-12-01013]\]. MD prevents the development of CVD, breast cancer, depression, colorectal cancer, diabetes, obesity, asthma, and cognitive decline \[[@B42-nutrients-12-01013]\], and decreases prevalence of MetS and cardiometabolic risk factors \[[@B9-nutrients-12-01013]\] but can also reverse MetS conditions \[[@B10-nutrients-12-01013]\]. Such results are related to our findings which showed a tendency towards higher MD adherence in participants with the lowest MetSSS. The evidence shows that food comprising MD has a cardioprotective effect, improving cardiovascular health and reducing CVD morbidity and mortality. This effect is caused by improving vascular function (improving hyperemia indices, reducing inflammation, improving platelet function, and enhancing nitric oxide (NO) utilization and availability) and lipid profiles (reducing LDL-c, TG, increasing HDL-c, and reducing LDL-oxidation), reducing BP (improving vascular function, reducing inflammation, reducing reactive oxygen species (ROS), and enhancing NO utilization), reducing oxidative stress (reducing LDL-oxidation, improving anti-oxidant capacity, reducing ROS, and reducing isoprostanes) and reducing weight (reducing ROS, lipid profile and BP, and improving exercise capacity) \[[@B44-nutrients-12-01013]\]. This is in accordance with the tendency of highest MetSSS participants towards a lower MD adherence.

Inflammation is an underlying pathophysiological process in chronic diseases, such as obesity, T2DM, and CVD. A pro-inflammatory diet is associated with increased all-cause mortality. In addition, pro-inflammatory diets are associated with an increased risk of MetS \[[@B45-nutrients-12-01013]\]. Our results also agree these previous findings, as well as that a pro-inflammatory state is one component of MetS \[[@B46-nutrients-12-01013]\].

Our results also agree previous findings in which total, red, and processed meat consumption is positively associated with MetS \[[@B27-nutrients-12-01013]\], which could potentially increase the risk of chronic diseases, including T2DM, CVD, and several types of cancer \[[@B47-nutrients-12-01013]\]. Conversely, our lowest severity MetSSS participants tended to have a higher intake of white meat, like previous findings that showed an inverse association between white meat intake and MetS \[[@B28-nutrients-12-01013]\].

The higher intakes of total protein, total fat, SFA, TFA, and cholesterol showed by the highest MetSSS may have been due to the high consumption of total, red, and processed meat and other oils and fats different from olive oil, and it is consistent with previous results in which the quality and the amount of FA intake were associated with risk of MetS \[[@B48-nutrients-12-01013]\]. Previous findings showed a decrease in cardiovascular risk on reductions of SFA intake \[[@B49-nutrients-12-01013]\], like our results on lower SFA intake in lower severity MetSSS participants. Previous evidence has shown a positive association between TFA intake and the development of CVD \[[@B50-nutrients-12-01013]\], which is in accordance with our results. Omega-3 FA decreases the production of inflammatory mediators, having a positive effect on obesity and T2DM, decreasing the appearance of CVD risk factors, and conferring cardioprotection due to their blood pressure lowering and anti-inflammatory properties \[[@B51-nutrients-12-01013]\]. Our findings on highest MetSSS participants that tended to have lower ω-3 FA intake may be understood under this umbrella.

Carbohydrate intake stimulates insulin secretion, promoting fat storage and strongly inhibiting adipose tissue lipolysis and fatty acid oxidation. In this way, low-carbohydrate diets seem to ameliorate insulin resistance and MetS \[[@B52-nutrients-12-01013]\]. Our results showed, however, that higher levels of carbohydrate intake in participants led to the lowest levels of MetSSS risk, but it is important to highlight that the kind of carbohydrate is of considerable importance, where fruits, vegetables, legumes, and whole grains are appropriate sources of carbohydrates with cardioprotective components. Our results on lower intakes of nuts among the highest MetSSS subjects are in accordance with previous findings that pointed out how a higher consumption of nuts was inversely associated with total CVD and CHD \[[@B25-nutrients-12-01013]\], and nut consumption, especially walnuts, showed a significant, inverse association with MetS risk \[[@B53-nutrients-12-01013]\]. Despite dairy products being one of the richest sources of iodine \[[@B54-nutrients-12-01013]\], their intake is not significantly increased in highest MetSSS subjects. Moreover, consumption of other iodine sources \[fish, fruits, and vegetables\] were no different between participants with different MetSSS. Accordingly, the higher iodine and sodium intake among the highest MetSSS participants could be related with the increased consumption of processed meat products \[[@B55-nutrients-12-01013]\] in these participants, also associated with higher CVD risk \[[@B56-nutrients-12-01013]\].

Finally, the relationship between alcohol consumption and CVD is complex and controversial. High alcohol consumption is associated with both dyslipidaemia and high glycosylated haemoglobin, \[[@B57-nutrients-12-01013]\] and alcohol abuse has been shown to increase mortality and cardiovascular risk \[[@B26-nutrients-12-01013]\]. These observations are in accordance with our findings in which participants with the highest MetSSS showed a higher intake of spirits.

4.6. Strengths and Limitations {#sec4dot6-nutrients-12-01013}
------------------------------

The main strength of this study was that, to our knowledge, it is the first study to examine lifestyle factors, such as LTPA, dietary characteristics, sedentary behaviour, and depressive symptoms in older adults with MetS according to MetS severity. Another strength of our study is that a large sample of older adults living in the Mediterranean area with MetS was assessed. In addition, the FFQ used to collect information on nutrient intake took nutritional supplements, such as multivitamins and minerals, into consideration as a contribution to micronutrient intake. However, supplement use could also be considered as a confounding factor. The study also has several limitations. First, although the FFQ is a validated tool, it could overestimate the intake of certain food groups. Second, the use of self-reported data to evaluate PA has inherent limitations, as questionnaires overestimate the engagement in PA. Third, this cross-sectional study limits the ability to elucidate a causal relationship between MetS and lifestyle factors.

5. Conclusions {#sec5-nutrients-12-01013}
==============

Older adults with most severe MetS showed lower moderate and vigorous LTPA and higher levels of sedentary time and depression risk and tended to have a pro-inflammatory dietary pattern and lower MD adherence. As this was an observational study, future studies will need to elucidate the causal relationship between the severity of MetS and lifestyle factors. This approach provided new and useful information for determining prevention and treatment plans in a population as heterogeneous as patients with MetS, according to the severity of the disease.
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###### 

Baseline characteristics of participants according to tertiles of the Metabolic Syndrome Severity Score (MetSSS).

  ----------------------------------------------------------------------------------------------
  Variables                         Tertile 1\       Tertile 2\       Tertile 3\     *p*-Value
                                    (*n* = 1913)     (*n* = 1913)     (*n* = 1913)   
  --------------------------------- ---------------- ---------------- -------------- -----------
  Women, *n* (%)                    704 (36.8)       981 (51.3)       1054 (55.1)    \<0.001

  Age, years                        64.7 ± 5.1 ^a^   65.3 ± 4.9 ^a^   65.0 ± 4.9     \<0.001

  Prevalence of obesity, *n* (%)    1000 (52.3)      1535 (80.2)      1647 (86.1)    \<0.001

  Education level, *n* (%)          1899             1893             1895           \<0.001

  Illiterate or primary education   846 (44.5)       945 (49.9)       992 (52.3)     

  Secondary education               573 (30.2)       552 (29.2)       524 (27.7)     

  Academic or graduate              480 (25.3)       396 (20.9)       379 (20.0)     

  Smoking habit, *n* (%)            1904             1905             1909           \<0.001

  Never smoked                      749 (39.3)       852 (44.7)       904 (47.4)     

  Former smoker                     907 (47.6)       791 (41.5)       795 (41.6)     

  Current smoker                    248 (13.0)       262 (13.8)       210 (11.0)     

  Married status                    1902             1906             1910           0.012

  Single or divorced                242 (12.7)       261 (13.7)       261 (13.7)     

  Married                           1499 (78.8)      1442 (75.7)      1427 (74.7)    

  Widower                           161 (8.5)        203 (10.7)       222 (11.6)     

  Employment status, *n* (%)        1902             1904             1895           \<0.001

  Working                           455 (23.9)       342 (18.0)       367 (19.4)     

  Non-working                       372 (19.6)       435 (22.8)       508 (26.8)     

  Retired                           1075 (56.5)      1127 (59.2)      1020 (53.8)    

  MetS components, *n* (%)                                                           

  High blood pressure\              1719 (89.9)\     1750 (91.5)\     1801 (94.1)\   \<0.001\
  Hyperglycaemia\                   1322 (69.1)\     1435 (75.0)\     1558 (81.4)\   \<0.001\
  Hypertriglyceridemia\             1065 (55.7)\     1072 (56.0)\     1102 (57.6)\   0.440\
  Low HDL-cholesterol\              742 (38.8)\      837 (43.8)\      903 (47.2)\    \<0.001\
  Abdominal obesity                 1769 (92.5)      1859 (97.2)      1876 (98.1)    \<0.001

  Medication                                                                         

  Antihypertensive agents           1460 (76.3)      1466 (76.6)      1539 (80.4)    0.003

  Anti-cholesterol agents           966 (50.5)       964 (50.4)       1053 (55.0)    0.018

  Insulin                           36 (1.9)         64 (3.3)         174 (9.1)      \<0.001

  Oral hypoglycaemic agents         271 (14.2)       433 (22.6)       802 (41.9)     \<0.001

  Aspirin or antiplatelet drugs     240 (12.5)       278 (14.5)       376 (19.7)     \<0.001
  ----------------------------------------------------------------------------------------------

Data is presented as mean ± SD or as number of participants (percentage). Abbreviations: BMI: body-mass-index; HDL: high density lipoprotein. Differences in percentages were tested by chi-squared test and difference in means between tertiles were tested by Kruskal Wallis test for non-normally distributed variables with Bonferroni post-hoc correction. Differences (*p*-value \<0.05) between ^a^ Tertile 1 vs. Tertile 2.

nutrients-12-01013-t002_Table 2

###### 

Cardiovascular risk factors and Beck Depression Inventory-II according to tertiles of Metabolic Syndrome Severity Score (MetSSS).

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variables                        Tertile 1 (*n* = 1913)   Tertile 2 (*n* = 1913)   Tertile 3 (*n* = 1913)   *p*-Value      Sex and Age Adjusted\   Full Adjusted\                       
                                                                                                                             *p*-Value               *p*-Value                            
  -------------------------------- ------------------------ ------------------------ ------------------------ -------------- ----------------------- ---------------- --------- --------- ---------
  Weight, kg                       81.6 ± 11.0 ^a,b^        81.2 (16.1)              86.5 ± 11.9 ^a,c^        85.3 (16.9)    91.6 ± 13.9 ^b,c^       90.6 (19.0)      \<0.001   \<0.001   \<0.001

  BMI, kg/m^2^                     30.4 ± 2.3 ^a,b^         30.1 (3.3)               32.7 ± 3.0 ^a,c^         32.5 (4.3)     34.4 ± 3.6 ^b,c^        34.6 (5.7)       \<0.001   \<0.001   \<0.001

  Waist circumference, cm          101.7 ± 7.2 ^a,b^        102.0 (10.7)             107.7 ± 7.7 ^a,c^        107.0 (10.6)   113.1 ± 10.0 ^b,c^      113.0 (13.3)     \<0.001   \<0.001   \<0.001

  Women                            94.8 ± 4.3 ^a,b^         95.0 (6.5)               103.4 ± 5.0 ^a,c^        104.0 (6.4)    110.4 ± 9.0 ^b,c^       112.0 (11.4)     \<0.001   \<0.001   \<0.001

  Men                              105.7 ± 5.3 ^a,b^        106.0 (7.4)              112.3 ± 7.4 ^a,c^        113.5 (11.0)   116.4 ± 10.1 ^b,c^      116.0 (16.1)     \<0.001   \<0.001   \<0.001

  Glucose, mg/dL                   101.6 ± 12.5 ^a,b^       101.0 (17.0)             109.3 ± 17.8 ^a,c^       106.0 (24.0)   129.4 ± 40.4 ^b,c^      118.0 (48.0)     \<0.001   \<0.001   \<0.001

  Glycated haemoglobin,%           5.8 ± 0.5 ^a,b^          5.7 (0.5)                6.0 ± 0.6 ^a,c^          5.9 (0.7)      6.5 ± 1.2 ^b,c^         6.2 (1.4)        \<0.001   \<0.001   \<0.001

  Total cholesterol, mg/dL         196.0 ± 35.8             195.0 (50.0)             197.8 ± 38.2             196.0 (52.0)   194.3 ± 38.4            192.0 (51.0)     \<0.001   \<0.001   \<0.001

  HDL-cholesterol, mg/dL           49.2 ± 12.0 ^a,b^        47.0 (15.0)              47.8 ± 11.4 ^a^          46.0 (14.0)    46.8 ± 12.1 ^b^         46.0 (15.0)      \<0.001   \<0.001   \<0.001

  LDL-cholesterol, mg/dL           121.8 ± 41.2             119.0 (43.0)             122.8 ± 46.3             120.0 (44.0)   117.4 ± 40.5            114.0 (44.0)     \<0.001   \<0.001   \<0.001

  Triglycerides, mg/dL             133.4 ± 49.5 ^a,b^       127.0 (68.0)             151.0 ± 64.1 ^a,c^       138.0 (77.0)   171.8 ± 103.3 ^b,c^     144.0 (94.0)     \<0.001   \<0.001   \<0.001

  Systolic blood pressure, mmHg    134.1 ± 14.2 ^a,b^       133.3 (18.3)             138.5 ± 16.3 ^a,c^       137.3 (20.7)   143.9 ± 18.8 ^b,c^      142.0 (23.7)     \<0.001   \<0.001   \<0.001

  Diastolic blood pressure, mmHg   80.1 ± 8.4 ^a,b^         80.3 (11.0)              81.7 ± 9.5 ^a,c^         81.7 (12.7)    84.1 ± 10.8 ^b,c^       83.3 (15.0)      \<0.001   \<0.001   \<0.001

  Heart rate, bpm                  68.0 ± 9.9 ^a,b^         67.3 (13.0)              70.3 ± 10.5 ^a,c^        69.7 (14.0)    73.0 ± 11.2 ^b,c^       72.0 (14.9)      \<0.001   \<0.001   \<0.001

  Visceral adiposity index         2.0 ± 0.9 ^a,b^          1.8 (1.3)                2.5 ± 1.4 ^a,c^          2.2 (1.6)      3.0 ± 2.5 ^b,c^         2.4 (2.1)        \<0.001   \<0.001   \<0.001

  Beck Depression Inventory-II     7.5 ± 6.8 ^b^            6.0 (9.0)                8.4 ± 7.4 ^c^            7.0 (9.0)      9.5 ± 7.9 ^b,c^         8.0 (9.0)        \<0.001   \<0.001   \<0.001
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: BMI: body mass index; CI: confidence interval. Differences among tertiles of MetS Severity Score were tested by 1-factor ANOVA (*p*-value) and ANCOVA, adjusted *p*-value for sex and age, and full adjusted p-value for sex, age, education level, smoking habit, married and employment status and medication used. Bonferroni post-hoc correction was used for multiple comparisons. Differences (full adjusted *p*-value \<0.05) between ^a^ Tertile 1 vs. Tertile 2, ^b^ Tertile 1 vs. Tertile 3, ^c^ Tertile 2 vs. Tertile 3.
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###### 

Physical activity parameters and sedentary behaviour according to tertiles of MetS Severity Score.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Varibles                     Tertile 1 (*n* = 1913)   Tertile 2 (*n* = 1913)   Tertile 3 (*n* = 1913)   *p*-Value       Sex and Age Adjusted\   Full Adjusted\                       
                                                                                                                          *p*-Value               *p*-Value                            
  ---------------------------- ------------------------ ------------------------ ------------------------ --------------- ----------------------- ---------------- --------- --------- ---------
  Sedentary time, h/d          7.9 ± 1.9 ^a,b^          8.0 (2.7)                8.0 ± 1.9 ^a^            8.0 (2.9)       8.2 ± 2.0 ^b^           8.0 (3.3)        \<0.001   \<0.001   \<0.001

  TV-viewing time, h/d         5.0 ± 1.7 ^b^            5.0 (2.0)                5.2 ± 1.8                5.0 (2.3)       5.3 ± 1.9 ^b^           5.0 (2.4)        \<0.001   \<0.001   0.003

  Sleeping time, h/d           7.0 ± 1.2                7.0 (2.0)                7.1 ± 1.2                7.0 (2.0)       7.0 ± 1.3               7.0 (2.0)        0.128     0.056     0.081

  Total LTPA, MET·min/d        378.4 ± 282.3 ^a,b^      311.7 (360.8)            335.0 ± 272.4 ^a^        267.2 (353.3)   307.3 ± 261.1 ^b^       239.8 (303.7)    \<0.001   \<0.001   \<0.001

  Light LTPA, MET·min/d        115.3 ± 140.9            71.9 (159.8)             110.3 ± 132.6            63.9 (159.8)    110.7 ± 126.3           79.9 (151.9)     0.433     0.588     0.417

  Moderate LTPA, MET·min/d     147.7 ± 195.7 ^b^        74.9 (224.8)             128.0 ± 183.9            40.0 (199.8)    111.0 ± 181.9 ^b^       10.0 (159.8)     \<0.001   \<0.001   \<0.001

  Vigorous LTPA, MET·min/d     115.4 ± 184.8 ^a,b^      18.0 (163.3)             96.7 ± 164.8 ^a^         12.0 (137.2)    85.7 ± 155.8 ^b^        8.0 (105.6)      \<0.001   \<0.001   \<0.001

  30-s chair stand test, *n*   14.1 ± 5.0 ^a,b^         14.0 (6.0)               13.2 ± 5.0 ^a,c^         13.0 (5.0)      12.5 ± 4.9 ^b,c^        12.0 (5.0)       \<0.001   \<0.001   \<0.001
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: IQR: interquartile range; LTPA: leisure time physical activity; s: second; SD: standard deviation. Differences among tertiles of MetS Severity Score were tested by 1-factor ANOVA (*p*-value) and ANCOVA, adjusted p-value for sex and age, and full adjusted *p*-value for sex, age, education level, smoking habit, married and employment status. Bonferroni post-hoc correction was used for multiple comparisons. Differences (full adjusted *p*-value \<0.05) between ^a^ Tertile 1 vs. Tertile 2, ^b^ Tertile 1 vs. Tertile 3, ^c^ Tertile 2 vs. Tertile 3.
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###### 

Energy and nutrient intake according to tertiles of Metabolic Syndrome Severity Score (MetSSS).

  Vriables                    Tertile 1 (*n* = 1913)   Tertile 2 (*n* = 1913)   Tertile 3 (*n* = 1913)   *p*-Value         Sex and Age Adjusted *p*-Value   Full Adjusted *p*-Value                       
  --------------------------- ------------------------ ------------------------ ------------------------ ----------------- -------------------------------- ------------------------- --------- --------- ---------
  Total energy (TE), kcal/d   2392.7 ± 547.8           2354.1 (724.4)           2359.0 ± 553.9           2329.5(758.7)     2345.7 ± 549.1                   2321.2 (764.6)            0.024     0.733     0.640
  Total fat intake, %TE       39.0 ± 6.3 ^a,b^         39.0 (8.7)               39.8 ± 6.6 ^a^           39.8 (8.7)        39.6 ± 6.5 ^b^                   39.6 (9.1)                0.001     0.002     0.003
  MUFA, % TE                  20.2 ± 4.6 ^a^           20.1 (6.0)               20.7 ± 4.7 ^a^           20.6 (6.4)        20.4 ± 4.6                       20.2 (6.5)                0.005     0.012     0.023
  PUFA, %TE                   6.4 ± 1.8                6.1 (2.2)                6.4 ± 1.8                6.1 (2.3)         6.3 ± 1.9                        6.0 (2.2)                 0.450     0.415     0.457
  SFA,%TE                     9.8 ± 2.0 ^a,b^          9.6 (2.6)                10.0 ± 2.0 ^a^           9.9 (2.5)         10.1 ± 2.0 ^b^                   10.0 (2.6)                0.001     \<0.001   \<0.001
  Trans FA, g/d               0.6 ± 0.4 ^b^            0.5 (0.5)                0.6 ± 0.4                0.5 (0.5)         0.6 ± 0.4 ^b^                    0.5 (0.5)                 0.225     0.056     0.029
  Linoleic acid, g/d          13.8 ± 5.6               12.8 (7.0)               13.6 ± 5.5               12.7 (7.3)        13.4 ± 5.7                       12.3 (6.8)                0.194     0.805     0.830
  w-3 FA, g/d                 2.4 ± 0.9                2.3 (1.3)                2.4 ± 1.0                2.2 (1.3)         2.3 ± 0.9                        2.1 (1.2)                 0.005     0.014     0.049
  Carbohydrate intake, %TE    41.1 ± 6.7 ^a,b^         41.1 (9.4)               40.4 ± 6.9 ^a^           40.4 (9.2)        40.5 ± 6.9 ^b^                   40.5 (9.4)                0.008     \<0.001   \<0.001
  Glycaemic index             54.1 ± 5.1               54.4 (6.8)               53.7 ± 5.2               54.1 (6.8)        53.9 ± 5.1                       54.2 (6.7)                0.146     0.367     0.557
  Protein intake, %TE         16.5 ± 2.8 ^b^           16.2 (3.6)               16.8 ± 2.8               16.7 (3.7)        17.1 ± 2.9 ^b^                   16.9 (3.6)                \<0.001   0.002     0.003
  Cholesterol, mg/d           382.1 ± 118.8 ^b^        369.5 (136.9)            380.3 ± 119.3            168.8 (143.3)     386.4 ± 113.4 ^b^                374.5 (135.9)             0.251     0.013     0.006
  Fibre intake, g/d           26.3 ± 9.0               24.7 (11.0)              26.3 ± 9.0               25.0 (11.0)       25.9 ± 8.4                       25.0 (10.6)               0.300     0.061     0.094
  Alcohol intake, g/d         12.3 ± 15.3              6.2 (15.4)               10.4 ± 14.1              4.7 (13.0)        10.4 ± 15.6                      4.3 (11.9)                \<0.001   0.509     0.457
  Vitamin A, µg/d             1111.9 ± 639.7           936.8 (781.5)            1098.8 ± 654.4           929.0 (753.1)     1120.0 ± 638.8                   936.7 (766.4)             0.592     0.583     0.480
  Vitamin B1, mg/d            1.6 ± 0.4                1.6 (0.5)                1.6 ± 0.4                1.6 (0.6)         1.6 ± 0.4                        1.6 (0.5)                 0.935     0.840     0.742
  Vitamin B2, mg/d            2.0 ± 0.6                1.9 (0.8)                2.0 ± 0.7                1.9 (0.8)         2.0 ± 0.6                        1.9 (0.8)                 0.271     0.619     0.497
  Vitamin B3, mg/d            40.6 ± 10.0              40.0 (13.8)              40.8 ± 10.0              40.4 (12.9)       41.0 ± 9.9                       40.5(12.7)                0.386     0.219     0.151
  Vitamin B6, mg/d            2.4 ± 0.6                2.3 (0.8)                2.4 ± 0.6                2.3 (0.8)         2.3 ± 0.6                        2.3 (0.8)                 0.283     0.237     0.344
  Vitamin B9, µg/d            352.5 ± 104.8            336.8 (134.3)            353.5 ± 103.7            338.1 (126.7)     349.3 ± 99.4                     339.0 (125.8)             0.419     0.222     0.279
  Vitamin B12, µg/d           10.0 ± 4.6               9.2 (5.8)                10.0 ± 4.4               9.1(5.5)          10.1 ± 4.5                       9.2(5.6)                  0.400     0.200     0.212
  Vitamin C, mg/d             200.2 ± 87.8             184.5(108.1)             204.7 ± 86.3             188.6(114.7)      200.2 ± 83.7                     187.0 (104.6)             0.166     0.138     0.156
  Vitamin D, µg/d             6.3 ± 3.5                5.2 (5.4)                6.2 ± 3.4                5.2 (5.4)         6.1 ± 3.5                        5.0 (5.0)                 0.230     0.189     0.232
  Vitamin E, mg/d             10.6 ± 4.0               10.0 (4.3)               10.6 ± 3.9               10.0 (4.3)        10.6 ± 4.1                       9.9 (4.3)                 0.966     0.733     0.646
  Calcium, mg/d               1026.7 ± 339.7           984.8 (431.9)            1040.9 ± 348.3           997.3 (453.8)     1038.1 ± 350.2                   997.4 (449.6)             0.409     0.475     0.320
  Phosphorus, mg/d            1749.5 ± 411.4           1715.6 (540.9)           1765.1 ± 431.6           1733.7 (597.4)    1769.1 ± 422.0                   1736.1 (558.2)            0.315     0.294     0.149
  Magnesium, mg/d             423.1 ± 109.0            409.5 (142.6)            422.6 ± 111.2            410.9 (143.9)     417.1 ± 106.3                    405.5 (145.7)             0.171     0.241     0.372
  Iron, mg/d                  16.6 ± 4.0               16.3 (5.4)               16.5 ± 4.0               16.2 (5.1)        16.4 ± 3.9                       16.1 (5.2)                0.355     0.958     0.999
  Iodine, µg/d                274.1 ± 154.8 ^b^        256.5 (130.5)            288.3 ± 162.7            258.9 (140.4)     290.8 ± 158.8 ^b^                259.7 (125.6)             0.002     0.030     0.019
  Potassium, mg/d             4457.1 ± 1067.4          4346.5 (1401.0)          4493.8 ± 1101.2          4396.4 (1441.6)   4466.5 ± 1077.9                  4365.2 (1374.5)           0.552     0.686     0.700
  Selenium, µg/d              117.6 ± 33.4             114.9 (42.7)             116.6 ± 33.4             114.2 (44.5)      117.6 ± 32.4                     115.4 (43.1)              0.545     0.428     0.280
  Zinc, mg/d                  13.2 ± 3.3               12.9 (4.3)               13.2 ± 3.3               12.9 (4.5)        13.2 ± 3.2                       13.0 (4.2)                0.969     0.400     0.257
  Sodium, mg/d                2427.8 ± 760.3 ^b^       2332.5 (957.0)           2406.6 ± 794.1 ^c^       2312.1 (1008.0)   2459.4 ± 775.8 ^b,c^             2371.3 (976.7)            0.106     0.001     \<0.001

Abbreviations: IQR: interquartile range; MUFA: monounsaturated fatty acid; PUFA: polyunsaturated fatty acid; SD: standard deviation; SFA: saturated fatty acid; w-3 FA: omega-3 fatty acid. Differences among tertiles of MetS Severity Score were tested by 1-factor ANOVA (p-value) and ANCOVA, adjusted *p-value* for sex and age and full adjusted p-value for sex, age, education level, smoking habit, married and employment status. Bonferroni post-hoc correction was used for multiple comparisons. Differences (full adjusted p-value \< 0.05) between ^a^ Tertile 1 vs. Tertile 2, ^b^ Tertile 1 vs. Tertile 3, ^c^ Tertile 2 vs. Tertile 3.
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###### 

Food consumption, Dietary Inflammatory Index, and adherence to Mediterranean Diet according to tertiles of Metabolic Syndrome Severity Score (MetSSS).

  Variables                          Tertile 1 (*n* = 1913)   Tertile 2 (*n* = 1913)   Tertile 3 (*n* = 1913)   *p*-Value       Sex and Age Adjusted *p*-Value   Full Adjusted *p*-Value                       
  ---------------------------------- ------------------------ ------------------------ ------------------------ --------------- -------------------------------- ------------------------- --------- --------- ---------
  **Food groups**                                                                                                                                                                                              
  Fruits, g/d                        352.3 ± 203.4            320.4 (245.1)            361.6 ± 204.9            331.8 (246.2)   358.0 ± 210.0                    325.6 (252.0)             0.373     0.880     0.863
  Vegetables, g/d                    324.5 ± 138.1            304.3 (181.9)            329.6 ± 143.2            306.5 (170.8)   328.7 ± 139.7                    306.9 (177.8)             0.487     0.825     0.758
  Potatoes and tubers, g/d           64.9 ± 42.5              50.0 (67.1)              65.7 ± 43.0              50.0 (67.1)     65.2 ± 43.5                      50.0 (67.1)               0.858     0.789     0.746
  Legumes, g/d                       21.0 ± 11.0              20.0 (9.7)               20.8 ± 11.7              20.6 (13.1)     20.6 ± 11.1                      17.1 (12.6)               0.670     0.205     0.811
  Nuts, g/d                          15.9 ± 17.9 ^b^          10.3 (21.7)              15.3 ± 17.6 ^c^          8.6 (23.6)      13.5 ± 16.5 ^b,c^                8.0 (17.1)                \<0.001   \<0.001   \<0.001
  Cereals, g/d                       153.4 ± 79.3             126.4 (112.5)            147.8 ± 77.3             119.7 (116.0)   150.3 ± 74.5                     126.4 (112.5)             0.080     0.411     0.441
  Whole cereals                      41.9 ± 64.1              5.0 (75.0)               42.3 ± 63.6              5.0 (75.0)      41.1 ± 62.4                      4.0 (75.0)                0.831     0.173     0.307
  Refined cereals                    111.5 ± 89.1             92.1 (162.1)             105.5 ± 85.5             87.6 (161.2)    109.3 ± 85.5                     92.1 (160.7)              0.097     0.110     0.185
  Fish and seafood, g/d              101.9 ± 47.0             97.0 (64.0)              103.5 ± 49.3             99.5 (65.3)     102.0 ± 47.5                     96.0 (62.1)               0.504     0.557     0.757
  White fish                         38.9 ± 25.6              25.4 (42.9)              40.3 ± 27.0              25.4 (42.9)     40.4 ± 26.4                      25.4 (42.9)               0.160     0.690     0.570
  Bluefish                           35.0 ± 22.8              25.7 (37.1)              34.7 ± 22.5              25.7 (38.2)     34.0 ± 22.7                      25.7 (34.1)               0.354     0.253     0.311
  Seafood                            28.0 ± 21.2              30.6 (17.3)              28.6 ± 23.8              30.6 (17.3)     27.6 ± 21.3                      30.6 (17.3)               0.425     0.321     0.376
  Total meat, g/d                    144.7 ± 59.8 ^b,a^       138.5 (71.1)             147.2 ± 57.4 ^c,a^       143.0 (70.8)    152.0 ± 59.0 ^b,c^               146.9 (74.7)              \<0.001   \<0.001   \<0.001
  Red meat                           48.5 ± 35.1 ^a,b^        41.4 (46.2)              49.5 ± 34.0^a^           41.4 (46.2)     49.4 ± 34.2 ^b^                  42.8 (50.0)               0.596     0.004     0.002
  White meat                         60.3 ± 33.5              64.3 (42.9)              61.6 ± 33.8              64.3 (42.9)     64.2 ± 35.7                      64.3 (52.9)               0.002     0.029     0.066
  Processed meat                     33.8 ± 22.0 ^b^          30.6 (23.0)              34.1 ± 22.5 ^c^          31.3 (24.2)     36.2 ± 24.9 ^b,c^                32.4 (25.1)               0.002     \<0.001   \<0.001
  Viscera                            2.2 ± 5.3                0.0 (0.0)                2.1 ± 5.4                0.0 (0.0)       2.3 ± 5.3                        0.0 (0.0)                 0.517     0.295     0.328
  Eggs                               24.0 ± 12.4              25.7 (0.0)               23.6 ± 12.0              25.7 (0.0)      24.2 ± 11.5                      25.7 (0.0)                0.300     0.190     0.155
  Dairy products, g/d                332.5 ± 194.4            298.2 (189.4)            349.3 ± 203.3            310.2 (265.0)   351.6 ± 206.4                    304.6 (297.9)             0.006     0.125     0.077
  Whole-fat dairy                    45.5 ± 97.1              0.0 (53.6)               43.8 ± 96.5              0.0 (53.6)      45.3 ± 97.9                      0.0 (53.6)                0.829     0.522     0.541
  Skimmed dairy                      146.9 ± 160.5            125.0 (200.0)            156.8 ± 170.8            125.0 (209.5)   155.4 ± 175.1                    111.5 (209.5)             0.147     0.572     0.471
  Cheese                             29.8 ± 25.1              24.8 (32.4)              30.5 ± 24.6              24.8 (28.8)     30.9 ± 25.0                      25.0 (29.1)               0.387     0.470     0.287
  Dairy desserts                     16.0 ± 30.2              6.7 (15.3)               14.4 ± 25.5              6.7 (15.3)      15.2 ± 32.5                      6.7 (15.3)                0.272     0.574     0.534
  Cookies and sweets, g/d            26.9 ± 29.5              18.9 (32.7)              25.6 ± 28.6 ^c^          15.5 (30.7)     27.5 ± 30.7 ^c^                  17.8 (33.7)               0.108     0.081     0.041
  Olive oil, g/day                   39.2 ± 17.1              50.0 (25.0)              40.2 ± 16.8              50.0 (25.0)     39.0 ± 17.1                      50.0 (25.0)               0.048     0.030     0.054
  Other oils and fats, g/d           2.8 ± 6.2 ^b^            0.7 (2.2)                2.8 ± 6.2 ^c^            0.7 (3.0)       3.4 ± 7.0 ^b,c^                  0.8 (4.3)                 0.004     0.003     0.007
  Ready-to-eat-meals/Snacks, g/d     10.9 ± 14.1              5.3 (16.0)               10.7 ± 14.8              4.3 (16.7)      11.0 ± 14.6                      5.3 (16.0)                0.790     0.306     0.195
  Alcoholic drinks, ml/d                                                                                                                                                                                       
  Wine                               67.9 ± 107.5             14.3 (100.0)             54.3 ± 96.1              14.3 (78.6)     53.7 ± 100.7                     6.7 (49.5)                \<0.001   0.413     0.437
  Beer                               119.9 ± 216.8            22.0 (141.4)             112.0 ± 224.5            22.0 (141.4)    102.8 ± 222.4                    22.0 (141.4)              0.056     0.226     0.294
  Spirits                            3.7 ± 10.8 ^b^           0.0 (3.3)                3.0 ± 9.5 ^c^            0.0 (3.3)       3.9 ± 12.6 ^b,c^                 0.0 (3.3)                 0.020     0.001     0.001
  **Dietary Inflammatory Index**     −0.1 ± 2.0               −0.1 (3.1)               0.0 ± 2.1                0.0 (3.0)       0.1 ± 2.0                        0.1 (3.1)                 0.103     0.035     0.057
  **Mediterranean Diet Adherence**   8.5 ± 2.7                8.0 (4.0)                8.5 ± 2.7                8.0 (3.0)       8.4 ± 2.5                        8.0 (3.0)                 0.345     0.037     0.068

Abbreviations: IQR: interquartile range; SD: standard deviation. Differences among tertiles of MetS Severity Score were tested by 1-factor ANOVA (*p*-value) and ANCOVA, adjusted *p*-value for sex and age, and full adjusted p-value for sex, age, education level, smoking habit, married and employment status. Bonferroni post-hoc correction was used for multiple comparisons. Differences (full adjusted *p*-value \<0.05) between ^a^ Tertile 1 vs. Tertile 2, ^b^ Tertile 1 vs. Tertile 3, ^c^ Tertile 2 vs. Tertile 3.

[^1]: A complete list of the investigators in the PREDIMED-Plus is provided in the Acknowledgments.
